South Korea Battery for Medical Implantable Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Lithium Batteries, Zinc Air Batteries, Nickel Batteries, and Others), By Application (Cardiac Pacemakers, Neurostimulators, Implantable Cardioverter Defibrillators, Cochlear Implants, and Others), and South Korea Battery for Medical Implantable Devices Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea Battery for Medical Implantable Devices Market Insights Forecasts to 2035
- The South Korea Battery for Medical Implantable Devices Market Size is Expected to Grow at a CAGR of around 7.7% from 2025 to 2035
- The South Korea Battery for Medical Implantable Devices Market Size is Expected to hold a significant Share by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the South Korea Battery for Medical Implantable Devices Market is anticipated to grow at a CAGR of 7.7% from 2025 to 2035. The market is driven by rising adoption of implantable medical devices such as pacemakers, neurostimulators, cochlear implants, and insulin pumps. Advancements in lithium-ion, zinc-air, and other battery chemistries, as well as the need for long-lasting, reliable power sources, further support market growth.
Market Overview
The South Korea market for batteries for medical implantable devices is defined as the battery market associated with the healthcare industry where batteries are used to provide reliable, long-term power for medical device. The batteries used in implantable medical devices are important for keeping the device working and safe for use by patients. There is significant growth in this market as the prevalence of chronic diseases rises, the aging population expands, and healthcare providers are more frequented to using more advanced implantable devices. Battery technology variations have also evolved - lithium-ion and zinc-air batteries for powering implantable medical device, battery chemistries and devices are improving (i.e. miniaturization, efficiency, and safety). The infrastructure of the batteries for medical implantable devices market in South Korea has been functional for decades, improving with a more well-established distribution, easy access and online orientation, and a rising opportunity for home-based medical care, which have also contributed momentum to the growth. Overall, the market is expected to expand at a steady rate until the year of 2035, because of the already well-established healthcare infrastructure and adoption of medical implantable devices.
Report Coverage
This research report categorizes the market for the South Korea battery for medical implantable devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea battery for medical implantable devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea battery for medical implantable devices market.
South Korea Battery for Medical Implantable Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 7.7% |
Historical Data for: | 2020-2023 |
No. of Pages: | 190 |
Tables, Charts & Figures: | 121 |
Segments covered: | By Product Type, By Application |
Companies covered:: | Medtronic, Boston Scientific Corporation, Abbott Laboratories, BIOTRONIK SE & Co. KG, LivaNova PLC, Stryker Corporation, Others. |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The South Korea market for batteries and battery systems for medical implantable devices is driven primarily by the increasing utilization of implantable medical devices, including neuro stimulators, cochlear implants, and pacemakers. The increase in chronic disease prevalence, aging population, and the growing demand for safe, reliable batteries that last long term create further momentum for market growth. Furthermore, advancements in technology used in lithium-ion and zinc-air battery scheduled batteries to perform an increase of efficiency and ability to enhance the safety and miniaturization of medical devices, generating more market penetration for these devices.
Restraining Factors
Market expansion is restrained by high productivity and development expenditures, complex regulatory processes, battery disposal and recycling challenges, safety nuances, and limited reimbursement for a few implantable devices in some segments.
Market Segmentation
The South Korea battery for medical implantable devices market share is classified into product type and application.
- The lithium batteries segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea battery for medical implantable devices market is segmented by product type into lithium batteries, zinc air batteries, nickel batteries, and others. Among these, the lithium batteries segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is based on their high energy density, long life span, and ability to be used in implantable devices. In addition, zinc air and nickel batteries provide alternatives for certain applications, while other developing chemistries can be used in specialized medical devices.
- The cardiac pacemakers segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea battery for medical implantable devices market is segmented by application into cardiac pacemakers, neurostimulators, implantable cardioverter defibrillators, cochlear implants, and others. Among these, the cardiac pacemakers segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is a result of the increasing occurrence of cardiac disorders and rising demand for dependable, long-life power sources. The neurostimulators, ICDs, and cochlear implant markets are all growing, while the others segment contains specialized implantable devices.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea battery for medical implantable devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Medtronic
- Boston Scientific Corporation
- Abbott Laboratories
- BIOTRONIK SE & Co. KG
- LivaNova PLC
- Stryker Corporation
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea battery for medical implantable devices market based on the below-mentioned segments:
South Korea Battery for Medical Implantable Devices Market, By Product Type
- Lithium Batteries
- Zinc Air Batteries
- Nickel Batteries
- Others
South Korea Battery for Medical Implantable Devices Market, By Application
- Cardiac Pacemakers
- Neurostimulators
- Implantable Cardioverter Defibrillators
- Cochlear Implants
- Others
Frequently Asked Questions (FAQ)
-
What is the expected growth rate of the South Korea Battery for Medical Implantable Devices Market?The market is expected to grow at a CAGR of 7.7% during the forecast period 2025-2035.
-
What is the South Korea market for batteries for medical implantable devices?It is the healthcare market segment focused on batteries that provide reliable, long-term power for implantable medical devices such as pacemakers, neurostimulators, cochlear implants, and insulin pumps.
-
What are the key drivers of market growth?Growth is driven by rising adoption of implantable medical devices, increasing prevalence of chronic diseases, an aging population, and technological advancements in lithium-ion, zinc-air, and other battery chemistries enhancing efficiency, miniaturization, and safety.
-
. What are the main restraints affecting the market?Market growth is restrained by high production and development costs, complex regulatory processes, battery disposal and recycling challenges, safety concerns, and limited reimbursement for certain implantable devices.
-
5. How is the market segmented by product type?The market is segmented into lithium batteries, zinc air batteries, nickel batteries, and others. Lithium batteries dominated in 2024 due to high energy density, long life span, and compatibility with implantable devices.
-
6. How is the market segmented by application?The market is segmented into cardiac pacemakers, neurostimulators, implantable cardioverter defibrillators, cochlear implants, and others. Cardiac pacemakers held the largest share in 2024, driven by increasing cardiac disorders and demand for reliable long-life batteries.
-
Who are the key players in the South Korea battery for medical implantable devices market?Key companies include Medtronic, Boston Scientific Corporation, Abbott Laboratories, BIOTRONIK SE & Co. KG, LivaNova PLC, Stryker Corporation, and Others.
Need help to buy this report?